Patient P-03179
Therapy response
Stable
Tolerance
Deteriorating
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
20%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S05
- Day 13 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 18 GI-04 recommended — GI Support Protocol GI-04
- Day 19 Patient accepted — Started GI-04 in the companion
- Day 27 GI symptom burden −21% vs expected — GI Support Protocol GI-04
- Day 33 Tolerance state changed — Unstable → Improving
What changed?
Trajectory began diverging from predicted response on Day 13.
Primary contributors, last 14 days
- Toxicity+8
- Inflammatory activity+5
- Nutritional resilience-5
- GI instability+3
- Treatment adherence-3
What helped?
- GI Support Protocol GI-04Day 18Result: symptom burden −21%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log6.2/10
worsening · -0.6 vs previous 14 d
Stress level
Daily log5/10
worsening · +0.3 vs previous 14 d
Pessimism score
Daily log4.7/10
worsening · +0.4 vs previous 14 d
Sleep quality
Wearable53.1/100
worsening · -3.4 vs previous 14 d
Libido
Daily log3.8/10
worsening · -0.3 vs previous 14 d
HRV
Wearable41.8 ms
stable · -1.0 vs previous 14 d
Toxicity
Blood24.8/100
worsening · +7.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 68 from the failing basin, 27 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -3.3 next day on high-intake days · n 14
Would not help
- AD-05 Adherence Supportonly 29% improved among 14 similar
- Keep fat lowGI +3.2 next day on high-intake days · n 22
- Keep alcohol lowGI +3 next day on high-intake days · n 16
- Keep lactose lowGI +2.1 next day on high-intake days · n 27
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.3supporter · 95%
- Dietary fat load+3.2detractor · 95%
- Alcohol+3detractor · 77%
- Lactose+2.1detractor · 68%
- Caffeine-1.6no signal · 43%
- Histamine load-1.1no signal · 38%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓35
- MicrobiomeButyrate capacity 36/100
- Drug metabolism and exposure ↑35
- DNADPYD *2A → slower clearance
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
- Autonomic recovery ↑20
- Wearable3,621 steps/day
DNA
Fictional pharmacogenomic panel
- DPYD *2A heterozygousSlower drug clearance
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 2.4 · butyrate capacity 36/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 41 ms
- Sleep
- 7.7 h
- Steps
- 2,861
- Resting HR
- 60 bpm
Daily log: GI score 20, nutritional resilience 60, adherence 93.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-03144 | 55% | S16 | HY-01 | improved | 52 |
| P-03255 | 50% | S01 | HY-01 | improved | 53 |
| P-03328 | 49% | S15 | GI-04 | improved | 59 |
| P-03375 | 46% | S09 | DT-01 | improved | 52 |
| P-03484 | 46% | S07 | DT-01 | improved | 49 |
| P-03213 | 45% | S02 | DT-01 | improved | 59 |
| P-03233 | 45% | S19 | DT-01 | improved | 47 |
| P-03244 | 45% | S08 | DT-01 | improved | 53 |
| P-03215 | 44% | S16 | HY-01 | improved | 44 |
| P-03317 | 44% | S08 | HY-01 | improved | 45 |
| P-03408 | 44% | S09 | HY-01 | improved | 53 |
| P-03442 | 44% | S11 | DT-01 | improved | 51 |